US EditionPublished • loading... • Updated
Dual-action mRNA vaccine takes aim at aggressive skin cancer
Summary by Medical Xpress
1 Articles
1 Articles
Dual-action mRNA vaccine takes aim at aggressive skin cancer
Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting the protein essential to tumor cell growth and by adding a key signal to boost the immune system response. The findings are published in Cell Reports.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
